Literature DB >> 20647250

Characterization of the metabolic phenotype of chronically activated lymphocytes.

D R Wahl1, B Petersen, R Warner, B C Richardson, G D Glick, A W Opipari.   

Abstract

Activated lymphocytes proliferate, secrete cytokines, and can make antibodies. Normally activated B and T cells meet the bioenergetic demand for these processes by up-regulating aerobic glycolysis. In contrast, several lines of evidence suggest that pathogenic lymphocytes in autoimmune diseases like lupus meet ATP demands through oxidative phosphorylation. Using (13)C-glucose as a stable tracer, we found that splenocytes from mice with lupus derive the same fraction of lactate from glucose as control animals, suggesting comparable levels of glycolysis and non-oxidative ATP production. However, lupus splenocytes increase glucose oxidation by 40% over healthy control animals. The ratio between pentose phosphate cycle (PPC) activity and glycolysis is the same for each group, indicating that increased glucose oxidation is due to increased activity of the TCA cycle in lupus splenocytes. Repetitive stimulation of cultured human T cells was used to model chronic lymphocyte activation, a phenotype associated with lupus. Chronically activated T cells rely primarily on oxidative metabolism for ATP synthesis suggesting that chronic antigen stimulation may be the basis for the metabolic findings observed in lupus mice. Identification of disease-related bioenergetic phenotypes should contribute to new diagnostic and therapeutic strategies for immune diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647250     DOI: 10.1177/0961203310373109

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  44 in total

1.  Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.

Authors:  Erin Gatza; Daniel R Wahl; Anthony W Opipari; Thomas B Sundberg; Pavan Reddy; Chen Liu; Gary D Glick; James L M Ferrara
Journal:  Sci Transl Med       Date:  2011-01-26       Impact factor: 17.956

2.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 3.  Metabolic abnormalities and oxidative stress in lupus.

Authors:  Yaima L Lightfoot; Luz P Blanco; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

Review 4.  Immune Cell Metabolism in Systemic Lupus Erythematosus.

Authors:  Seung-Chul Choi; Anton A Titov; Ramya Sivakumar; Wei Li; Laurence Morel
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

Review 5.  Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.

Authors:  Zijun Wang; Hai Long; Christopher Chang; Ming Zhao; Qianjin Lu
Journal:  Cell Mol Life Sci       Date:  2018-07-04       Impact factor: 9.261

Review 6.  Mitochondria in the regulation of innate and adaptive immunity.

Authors:  Samuel E Weinberg; Laura A Sena; Navdeep S Chandel
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

7.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 8.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 9.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 10.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.

Authors:  Daniel R Wahl; Craig A Byersdorfer; James L M Ferrara; Anthony W Opipari; Gary D Glick
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.